Cardio Diagnostics Holdings Inc • CDIO

Capital at risk.

About Cardio Diagnostics Holdings Inc
Ticker
info
CDIO
Trading on
info
NASDAQ
ISIN
info
US14159C1036
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Meeshanthini V. Dogan Ph.D.
Headquarters
info
311 West Superior Street, Chicago, IL, United States, 60654
Employees
info
13
Website
info
https://cdio.ai
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Metrics
BasicAdvanced
Market cap
info
$22.3M
P/E ratio
info
-
EPS
info
-$0.31
Dividend Yield
info
0.00%
Beta
info
3.68
Forward P/E ratio
info
0
EBIDTA
info
$-8.1M
Ex dividend date
info
-
Price & volume
Market cap
info
$22.3M
Average daily volume
info
1.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
638.78
Price to book
info
2.33
Earnings
EPS
info
-$0.31
EPS estimate (current quarter)
info
-$0.06
EPS estimate (next quarter)
info
-$0.06
EBITDA
info
$-8.1M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
3.68
52-week High
info
$1.77
52-week Low
info
$0.19
50-day moving average
info
$0.42
200-day moving average
info
$0.45
Short ratio
info
2.37
Short %
info
3.81%
Management effectiveness
ROE (TTM)
info
133.96%
ROA (TTM)
info
69.36%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
33,608.20%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
15.00%
Share stats
Outstanding Shares
info
52.1M
Float
info
48.2M
Insiders %
info
7.55%
Institutions %
info
4.93%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$2.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.20
-$0.09
122.22%
Q1 • 24Beat
-$0.06
-$0.09
33.33%
Q2 • 24Beat
-$0.06
-$0.05
20.00%
Q3 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-1.4M
21,467.57%
Q3 • 24
$0M
$-1.5M
33,672.61%
Q4 • 24
31.43%
7.56%
56.85%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$4.5M
$0.8M
17.75%
Q3 • 24
$10.6M
$1.1M
9.96%
Q4 • 24
136.87%
32.98%
43.86%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-1.2M
$-0.1M
$1.9M
$-1.2M
Q3 • 24
$-1.4M
$-0.1M
$7.3M
$-1.4M
Q4 • 24
20.30%
30.49%
282.09%
17.07%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Cardio Diagnostics Holdings Inc share?
Collapse

Cardio Diagnostics Holdings Inc shares are currently traded for undefined per share.

How many shares does Cardio Diagnostics Holdings Inc have?
Collapse

Cardio Diagnostics Holdings Inc currently has 52.1M shares.

Does Cardio Diagnostics Holdings Inc pay dividends?
Collapse

No, Cardio Diagnostics Holdings Inc doesn't pay dividends.

What is Cardio Diagnostics Holdings Inc 52 week high?
Collapse

Cardio Diagnostics Holdings Inc 52 week high is $1.77.

What is Cardio Diagnostics Holdings Inc 52 week low?
Collapse

Cardio Diagnostics Holdings Inc 52 week low is $0.19.

What is the 200-day moving average of Cardio Diagnostics Holdings Inc?
Collapse

Cardio Diagnostics Holdings Inc 200-day moving average is $0.45.

Who is Cardio Diagnostics Holdings Inc CEO?
Collapse

The CEO of Cardio Diagnostics Holdings Inc is Dr. Meeshanthini V. Dogan Ph.D..

How many employees Cardio Diagnostics Holdings Inc has?
Collapse

Cardio Diagnostics Holdings Inc has 13 employees.

What is the market cap of Cardio Diagnostics Holdings Inc?
Collapse

The market cap of Cardio Diagnostics Holdings Inc is $22.3M.

What is the P/E of Cardio Diagnostics Holdings Inc?
Collapse

The current P/E of Cardio Diagnostics Holdings Inc is null.

What is the EPS of Cardio Diagnostics Holdings Inc?
Collapse

The EPS of Cardio Diagnostics Holdings Inc is -$0.31.

What is the PEG Ratio of Cardio Diagnostics Holdings Inc?
Collapse

The PEG Ratio of Cardio Diagnostics Holdings Inc is null.

What do analysts say about Cardio Diagnostics Holdings Inc?
Collapse

According to the analysts Cardio Diagnostics Holdings Inc is considered a buy.